三則公告回擊重組傳聞 “恆大系”股票集體大漲
格隆匯9月28日丨扭轉上週五的集體下跌態勢,今日恆大系股票集體反彈。其中,港股恆大汽車和恆騰網絡大漲超11%,中國恆大漲超9%,A股嘉凱城漲超6%。中國恆大連發三則公告迴應重組傳聞:1)中國恆大澄清,公司經營正常健康、財務穩健,截至2020年9月24日,公司有息負債較2020年3月末已下降約534億元,融資成本下降2.24個百分點,提前歸還2020年9月25日以後到期借款435億元,各項降負債成效積極顯著。2)恆大汽車公告,擬申請在科創板上市,發行不超過15.55億股股份。3)中國恆大稱,已收到聯交所對建議分拆物業管理業務的批准。此外,今早中譽集團宣佈斥資864萬美元收購中國恆大票據。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.